Efficacy and Safety of Calcineurin-Inhibitor-Free De-Novo Immunosuppression with Everolimus after Liver Transplantation

被引：0
|
作者：
Grazi, Gian Luca [1 ]
Cescon, Matteo [2 ]
Di Gioia, Paolo [1 ]
Ravaioli, Matteo [1 ]
Ponte, Elisa [1 ]
Sacchetti, Federico [1 ]
Vetrone, Gaetano [1 ]
Ercolani, Giorgio [1 ]
Morelli, Maria Cristina [1 ]
Pinna, Antonio D. [1 ]
机构：
[1] Univ Bologna, Policlin S Orsola Malpighi, Liver & Multiorgan Transplant Unit, Bologna, Italy
[2] Regina Elena Inst Canc Res, Hepatobiliary Pancreat Surg Unit, Rome, Italy
来源：
LIVER TRANSPLANTATION | 2011年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [21] CNI-free immunosuppression in de-novo kidney transplantation
    Figueiro, Jose M.
    Villaca, Sandra S.
    Gontijo, Ricardo C.
    Diniz, Mucio P.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 115 - 115
  • [22] Calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolatmofetil after cardiac transplantation is safe and improves renal function significantly
    Groetzner, J
    Meiser, BM
    Mueller, M
    Kaczmarek, I
    Buehse, L
    Vogeser, M
    Schirmer, J
    Koglin, J
    Reichart, B
    [J]. CIRCULATION, 2002, 106 (19) : 325 - 325
  • [23] Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo - Single Center Experience
    Stronka, M.
    Adamska, Z.
    Cichanska, L.
    Kubiak, J.
    Gamrat, M.
    Karczewski, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [24] Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
    Busque, S.
    Leventhal, J.
    Brennan, D. C.
    Steinberg, S.
    Klintmalm, G.
    Shah, T.
    Mulgaonkar, S.
    Bromberg, J. S.
    Vincenti, F.
    Hariharan, S.
    Slakey, D.
    Peddi, V. R.
    Fisher, R. A.
    Lawendy, N.
    Wang, C.
    Chan, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) : 1936 - 1945
  • [25] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Foltys, D.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 125 - 126
  • [26] SIROLIMUS CONVERSION TO ACHIEVE CALCINEURIN-INHIBITOR-FREE, STEROID-FREE IMMUNOSUPPRESSION
    Dhanda, Raman
    Shah, Yaser
    Cho, Alexander
    Howse, Matthew
    Bakran, Ali
    Hammad, Abdul
    Sharma, Ajay Kumar
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 352 - 352
  • [27] De-novo autoimmune hepatitis after liver transplantation
    Hadzic, N
    Vergani, D
    Mieli-Vergani, G
    [J]. AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 62 - 66
  • [28] DE-NOVO HYPERTENSION AFTER LIVER-TRANSPLANTATION
    TEXTOR, SC
    [J]. HYPERTENSION, 1993, 22 (02) : 257 - 267
  • [29] De-novo autoimmune hepatitis after liver transplantation
    Kerkar, N
    Hadzic, N
    Davies, ET
    Portmann, B
    Donaldson, PT
    Rela, M
    Heaton, ND
    Vergani, D
    Mieli-Vergani, G
    [J]. LANCET, 1998, 351 (9100): : 409 - 413
  • [30] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (vol 377, pg 837, 2011)
    Budde, K.
    Becker, T.
    Arns, W.
    [J]. LANCET, 2011, 377 (9782): : 2006 - 2006
12345